These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25494110)

  • 1. Serum levels of interleukin-7 and interleukin-8 in head and neck squamous cell carcinoma.
    Mojtahedi Z; Khademi B; Erfani N; Taregh Y; Rafati Z; Malekzadeh M; Ghaderi A
    Indian J Cancer; 2014; 51(3):227-230. PubMed ID: 25494110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of IL-18 in patients with head and neck squamous cell carcinoma.
    Riedel F; Adam S; Feick P; Haas S; Götte K; Hörmann K;
    Int J Mol Med; 2004 Feb; 13(2):267-72. PubMed ID: 14719133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
    Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
    J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
    Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
    Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-8 as a modulator of response to bevacizumab in preclinical models of head and neck squamous cell carcinoma.
    Gyanchandani R; Sano D; Ortega Alves MV; Klein JD; Knapick BA; Oh S; Myers JN; Kim S
    Oral Oncol; 2013 Aug; 49(8):761-70. PubMed ID: 23623402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase.
    Cohen AN; Veena MS; Srivatsan ES; Wang MB
    Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):190-7. PubMed ID: 19221248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression.
    Mojtahedi Z; Khademi B; Hashemi SB; Abtahi SM; Ghasemi MA; Fattahi MJ; Ghaderi A
    Pathol Oncol Res; 2011 Mar; 17(1):7-10. PubMed ID: 20340055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin-12 and interleukin-18 levels in patients with oesophageal squamous cell carcinoma.
    Diakowska D; Markocka-Maczka K; Grabowski K; Lewandowski A
    Exp Oncol; 2006 Dec; 28(4):319-22. PubMed ID: 17285118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells.
    Martone T; Bellone G; Pagano M; Beatrice F; Palonta F; Emanuelli G; Cortesina G
    Head Neck; 2004 Jun; 26(6):494-503. PubMed ID: 15162350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of interleukin (IL)-13, IL-17 and IL-18 in patients with ischemic heart disease.
    Jafarzadeh A; Esmaeeli-Nadimi A; Nough H; Nemati M; Rezayati MT
    Anadolu Kardiyol Derg; 2009 Apr; 9(2):75-83. PubMed ID: 19357047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
    Riedel F; Götte K; Schwalb J; Hörmann K
    Anticancer Res; 2000; 20(5A):3045-9. PubMed ID: 11062721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of IL-10 in patients with ovarian carcinoma.
    Mustea A; Könsgen D; Braicu EI; Pirvulescu C; Sun P; Sofroni D; Lichtenegger W; Sehouli J
    Anticancer Res; 2006; 26(2C):1715-8. PubMed ID: 16617566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of interleukin-6 in head and neck squamous cell carcinoma is related to papillomavirus infection.
    Guerrera IC; Quetier I; Fetouchi R; Moreau F; Vauloup-Fellous C; Lekbaby B; Rousselot C; Chhuon C; Edelman A; Lefevre M; Nicolas JC; Kremsdorf D; Lacau Saint Guily J; Soussan P
    J Proteome Res; 2014 Feb; 13(2):1002-11. PubMed ID: 24405156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma.
    Deng YF; Chen P; Lin YZ; Le JZ; Wu XL; Yu MQ; Zhuang PY; Gao MH
    J Laryngol Otol; 2003 Mar; 117(3):190-4. PubMed ID: 12648374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.
    Jacob SE; Nassiri M; Kerdel FA; Vincek V
    Mediators Inflamm; 2003 Oct; 12(5):309-13. PubMed ID: 14760939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining cancer cachexia in head and neck squamous cell carcinoma.
    Richey LM; George JR; Couch ME; Kanapkey BK; Yin X; Cannon T; Stewart PW; Weissler MC; Shores CG
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6561-7. PubMed ID: 18006755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
    Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
    Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.